Acorn Bioventures, L.P. — insider trades

Stock trades Acorn Bioventures, L.P. reported on SEC Form 4 at OKUR OnKure Therapeutics, Inc..

• May 15, 2025: bought 1,400,000 shares of OKUR OnKure Therapeutics, Inc. ($2.59M)